Table 2.
Clinical outcomes
| Variables | PCM group (n = 52) | Control group (n = 61) | P value |
|---|---|---|---|
| Encephalopathy score (Thompson score) | |||
| Day 1, Mean, min–max | 16 (9 – 21) | 17 (9 – 22) | n.s |
| At discharge, Mean, min–max | 5 (0 – 18) | 6 (0 – 18) | n.s |
| Complications during cooling – no. (%) | |||
| Hypotension ± inotropes | 30 (58) | 33 (54) | n.s |
| Pneumothorax | 2 (4) | 0 | n.s |
| Uncontrollable seizures | 4 (8) | 3 (5) | n.s |
| Sepsis | 10 (19) | 10 (16) | n.s |
| MRI at day 7–10 – no. (%) | |||
| White matter injury | 10 (19) | 11 (18) | n.s |
| Cerebral hemorrhage | 3 (6) | 1 (2) | n.s |
| Brain edema | 2 (4) | 1 (2) | n.s |
| Brain atrophy | 0 | 1 (2) | n.s |
| Deaths – n (%) | |||
| Total | 17 (33%) | 21 (34%) | n.s |
| Sarnat stage II | 2 | 3 | n.s |
| Sarnat stage III | 15 | 18 | n.s |